Summary
The concentrations of mepindolol in plasma and milk of five breastfeeding mothers were determined after 1 and 5 daily doses of mepindolol sulphate 20 mg. In the newborns plasma levels were measured once on the first and fifth days of the study. The mean maternal plasma concentration of mepindolol 2 h after administration was 52 ng/ml both after 1 and 5 doses; in the milk 18 and 22 ng/ml the corresponding concentrations were. The average plasma/milk drug concentration ratio was 2.6±1.6. Plasma levels in the newborns were below the detection limit of 1 ng/ml, except for one baby in whom 2 and 5 ng/ml, respectively, were found 4 h after one and five maternal doses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aellig WH (1973) Isoprenaline antagonism and duration of action in exercise induced tachycardia of three β-adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol. Br J Pharmacol 47: 621
Gugler R, Kreis L, Dengler HJ (1975) Pharmacokinetics of a new β-adrenoceptor blocking agent, LF 17–895, in man. Arzneim Forsch 25: 1067–1072
Bonelli J, Hitzenberger G, Krause W, Wendt H, Speck U (1980) Pharmacokinetics and pharmacodynamics of mepindolol sulphate. Int J Clin Pharmacol Ther Toxicol 18: 169–176
Krause W, Kühne G, Täuber U (1980) Pharmacokinetics of mepindolol sulphate in animals. Eur J Drug Metab Pharmacokin 5: 241–247
Krause W (1980) Determination of plasma mepindolol levels by high-performance liquid chromatography and electrochemical detection. J Chromatogr 181: 67–75
Abramowicz M (1974) Drugs in breast milk. Med Lett 16: 25–27
Abramowicz M (1979) Update: Drugs in breast milk. Med Lett 21: 21–24
Werthmann MW, Krees SV (1972) Excretion of chlorothiazide in human breast milk. J Pediatr 81: 781–783
Hümpel M, Stoppelli I, Milia S, Rainer E (1982) The pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam in humans. III. Repeated administration and transfer to newborns via breast milk. Eur J Clin Pharmacol 21: 421–425
Karlberg B, Lundberg D, Alberg H (1974) Excretion of propranolol in human breast milk. Acta Pharmacol Toxicol 34: 222–224
Bauer JH, Pape B, Zajicek I (1979) Propranolol in human plasma and breast milk. Am J Cardiol 43: 860–862
Dreyfuss I, Shaw JM, Miller TJ (1977) Nadolol: placental transfer and excretion in the milk of rats. Toxicol Appl Pharmacol 39: 275–282
Wilson JT, Brown RD, Cherek DR, Dailey JW, Hilman B, Jobe PC, Manno BR, Manno JE, Redetzki HM, Stewart JJ (1980) Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 5: 1–66
Hellenbrecht D, Lemmer B, Wiethold G, Grobecker H (1973) Measurement of hydrophobicity, surface activity, local anaesthesia and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine β-adrenergic blocking agents. Naunyn-Schmiedeberg's Arch Pharmacol 277: 211–226
Shand DG, Nuckolls EM, Dates JA (1970) Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther 11: 112–120
Nitowsky HM, Matz L, Berzowsky JA (1966) Studies on oxidative drug metabolism in the full-term newborn. Pediatr Pharmacol Ther 69: 1139–1149
Krauer B, Draffan GJ, Williams FM, Clara RA, Dollery CT, Hawkins DF (1973) Elimination kinetics of amobarbital in mothers and their newborn infants. Clin Pharmacol Ther 14: 442–447
Moore RG, Thomas J, Triggs EJ, Thomas D, Shanks CA (1976) The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. II. Mepivacaine. Eur J Clin Pharmacol 14: 203–212
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krause, W., Stoppelli, I., Milia, S. et al. Transfer of mepindolol to newborns by breast-feeding mothers after single and repeated daily doses. Eur J Clin Pharmacol 22, 53–55 (1982). https://doi.org/10.1007/BF00606425
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606425